(PDF) 536 Cat: In High-Risk Infants Hospitalised With

536 Cat: In High-Risk Infants Hospitalised With Bronchiolitis, Is the Use of Palivizumab (IG) Vaccine Warranted?

Pediatric Research - United States

doi 10.1203/00006450-201011001-00536

Full Text

Abstract

Available in full text

Categories

Date

November 1, 2010

Authors

Publisher

Springer Science and Business Media LLC

Related search

Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Infants With CHD &Premature Infants.

International Journal of Advanced Research

English

High-Flow Oxygen Therapy Is Safe and Effective in Infants With Bronchiolitis

Acta Paediatrica, International Journal of Paediatrics

English

O-018 Epinephrine Versus Placebo in Hospitalised Infants With Bronchiolitis Treated With Hypertonic Saline Solution

Archives of Disease in Childhood

English

Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis

Archives of Disease in Childhood: Fetal and Neonatal Edition

English

Initial Use of High-Flow Oxygen Did Not Reduce Duration of Oxygen Therapy in Infants With Bronchiolitis

Archives of Disease in Childhood: Education and Practice Edition

English

Using High-Flow Nasal Cannulas for Infants With Bronchiolitis Admitted to Paediatric Wards Is Safe and Feasible

Acta Paediatrica, International Journal of Paediatrics

English

Respiratory Syncytial Virus Bronchiolitis in Infants Is Associated With Predominant Th2-Like Response

Pediatric Research

English

Association of Serum Albumin With Apnea in Infants With Bronchiolitis

JAMA network open

English

Nasal High Flow in Room Air for Hypoxemic Bronchiolitis Infants

Frontiers in Pediatrics

English